Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin

Thirty five adult patients with precirrhotic primary sclerosing cholangitis were randomly allocated to treatment for at least one year with low dose (4.1 mg/kg/day) cyclosporin or placebo in a double blind trial. Thirty patients had coexisting ulcerative colitis, including three who had previously u...

Ausführliche Beschreibung